Status:
WITHDRAWN
Characterization of Beta Cell Failure
Lead Sponsor:
University Hospital Tuebingen
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Diabetes
Metabolic Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to characterise beta cell function in subjects who despite taking part in a diabetes prevention program (life style intervention with diet and exercise) exhibit impaired g...
Detailed Description
We have identified a subgroup of individuals with a good compliance to lifestyle intervention to prevent diabetes who lose body weight and increase insulin sensitivity, however they remain impaired gl...
Eligibility Criteria
Inclusion
- Impaired glucose tolerance
- BMI 16-40 kg/m²
Exclusion
- chronic disease
- anemia
- therapy with insulin or cortisone
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00869102
Start Date
May 1 2009
End Date
December 1 2011
Last Update
July 31 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tübingen
Tübingen, Germany, 72076